Status:
UNKNOWN
Hypofractionation And Ultra-Hypofractionation In Adjuvant Radiotherapy For Breast Cancer
Lead Sponsor:
Alexandria University
Conditions:
Breast Cancer
Eligibility:
FEMALE
50+ years
Phase:
NA
Brief Summary
Prospective randomized study comparing 5 fractions in alternative days to standard 15 fractions regarding effectiveness and feasibility during adjuvant treatment in breast caner patients aged above 50...
Detailed Description
In Alexandria, the number of working linear machines are limited with overcrowded waiting list which lead to prolongation of overall treatment time and delay in starting radiotherapy. Providing the av...
Eligibility Criteria
Inclusion
- Age ≥50 years old.
- Informed consent.
- Either breast conservative surgery or mastectomy.
- Invasive breast cancer with p T1-3, p N0-2.
- Non metastatic breast cancer proven by clinical examinations and imaging (X-ray chest and ultrasound or CT scan chest and abdomen).
Exclusion
- Evidence of distant metastases.
- Prior irradiation.
- Inflammatory breast cancer.
- Tumor with T4 (skin nodules or fixed to chest wall or ulceration).
- Tumor with positive margins.
Key Trial Info
Start Date :
June 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 28 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04434677
Start Date
June 28 2019
End Date
June 28 2021
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ACOD
Alexandria, Egypt